313 related articles for article (PubMed ID: 10759778)
1. Anti-MHC autoimmunity in Behçet's disease: T cell responses to an HLA-B-derived peptide cross-reactive with retinal-S antigen in patients with uveitis.
Kurhan-Yavuz S; Direskeneli H; Bozkurt N; Ozyazgan Y; Bavbek T; Kazokoglu H; Eksioglu-Demiralp E; Wildner G; Diedrichs-Möhring M; Akoglu T
Clin Exp Immunol; 2000 Apr; 120(1):162-6. PubMed ID: 10759778
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte proliferation induced by high-affinity peptides for HLA-B*51:01 in Behçet's uveitis.
Kaburaki T; Nakahara H; Tanaka R; Okinaga K; Kawashima H; Hamasaki Y; Rungrotmongkol T; Hannongbua S; Noguchi H; Aihara M; Takeuchi F
PLoS One; 2019; 14(9):e0222384. PubMed ID: 31513650
[TBL] [Abstract][Full Text] [Related]
3. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
[TBL] [Abstract][Full Text] [Related]
4. Differential recognition of a retinal autoantigen peptide and its variants by rat T cells in vitro and in vivo.
Wildner G; Diedrichs-Möhring M
Int Immunol; 2003 Aug; 15(8):927-35. PubMed ID: 12882830
[TBL] [Abstract][Full Text] [Related]
5. HLA and uveitis.
Feltkamp TE
Int Ophthalmol; 1990 Oct; 14(5-6):327-33. PubMed ID: 2249910
[TBL] [Abstract][Full Text] [Related]
6. Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.
Thurau SR; Diedrichs-Möhring M; Fricke H; Arbogast S; Wildner G
Immunol Lett; 1997 Jun; 57(1-3):193-201. PubMed ID: 9232451
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.
Wildner G; Thurau SR
Eur J Immunol; 1994 Nov; 24(11):2579-85. PubMed ID: 7957552
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen B27 and B51 double-positive Behçet uveitis.
Ahn JK; Park YG
Arch Ophthalmol; 2007 Oct; 125(10):1375-80. PubMed ID: 17923546
[TBL] [Abstract][Full Text] [Related]
9. Alpha tropomyosin as a self-antigen in patients with Behçet's disease.
Mahesh SP; Li Z; Buggage R; Mor F; Cohen IR; Chew EY; Nussenblatt RB
Clin Exp Immunol; 2005 May; 140(2):368-75. PubMed ID: 15807864
[TBL] [Abstract][Full Text] [Related]
10. Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.
Yamamoto JH; Minami M; Inaba G; Masuda K; Mochizuki M
Br J Ophthalmol; 1993 Sep; 77(9):584-9. PubMed ID: 8218058
[TBL] [Abstract][Full Text] [Related]
11. Gamma-delta T cells as orally induced suppressor cells in rats: in vitro characterization.
Wildner G; Thurau SR; Diedrichs-Möhring M
Ann N Y Acad Sci; 2004 Dec; 1029():416-21. PubMed ID: 15681796
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmological significance of HLA associated uveitis.
Feltkamp TE
Eye (Lond); 1990; 4 ( Pt 6)():839-44. PubMed ID: 2101117
[TBL] [Abstract][Full Text] [Related]
13. The comparison between Behçet's disease and spondyloarthritides: does Behçet's disease belong to the spondyloarthropathy complex?
Chang HK; Lee DH; Jung SM; Choi SJ; Kim JU; Choi YJ; Baek SK; Cheon KS; Cho EH; Won KS
J Korean Med Sci; 2002 Aug; 17(4):524-9. PubMed ID: 12172050
[TBL] [Abstract][Full Text] [Related]
14. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
[TBL] [Abstract][Full Text] [Related]
15. Retinal S-antigen Th1 cell epitope mapping in patients with Behcet's disease.
Zhao C; Yang P; He H; Lin X; Du L; Zhou H; Kijlstra A
Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):555-60. PubMed ID: 18958488
[TBL] [Abstract][Full Text] [Related]
16. HLA-B*27 allele associated to Behçet's disease and to anterior uveitis in Moroccan patients.
Radouane A; Oudghiri M; Chakib A; Naya A; Belhouari A; El Malki A; Bennani S
Ann Biol Clin (Paris); 2011; 69(4):419-24. PubMed ID: 21896406
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cellular immune response in Behçet's disease.
Kulaber A; Tugal-Tutkun I; Yentür SP; Akman-Demir G; Kaneko F; Gül A; Saruhan-Direskeneli G
Rheumatol Int; 2007 Oct; 27(12):1113-8. PubMed ID: 17549482
[TBL] [Abstract][Full Text] [Related]
18. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory and immunomodulatory peptides derived from the alpha1 domain of HLA-B27 in experimental autoimmune diseases in Lewis rats.
Diedrichs-Möhring M; Wildner G
Immunobiology; 2005; 209(10):711-7. PubMed ID: 15969447
[TBL] [Abstract][Full Text] [Related]
20. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
